NASDAQ · EYPT
EyePoint Pharmaceuticals, Inc.
Healthcare · Biotechnology
$0.36
Up+$0.00 (+1.15%)
Updated Nov 8, 2026, 6:27 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.11B
- P/E ratio
- -5.5
- Dividend yield
- 0.00%
- 52-week range
- $0.33 – $19.11
- Volume
- 5.98M
- Avg. volume
- 1.29M
Price performance · EYPT
EYPT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
EYPT closed at $0.36 after 20 trading sessions, down 89.16% for the selected period.
- Last close
- $0.36
- Period change
- -89.16%
- Period low
- $0.35
- Period high
- $3.32
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $0.3646 | $0.3646 | $0.3305 | $0.36 | 5.98M |
| Nov 5, 2026 | $0.395 | $0.395 | $0.3526 | $0.3559 | 4.22M |
| Nov 4, 2026 | $0.3921 | $0.409 | $0.3801 | $0.395 | 3.07M |
| Nov 3, 2026 | $0.3752 | $0.413 | $0.3752 | $0.3999 | 3.51M |
| Nov 2, 2026 | $0.35 | $0.3799 | $0.349 | $0.3748 | 6.33M |
| Oct 30, 2026 | $0.37 | $0.378 | $0.3446 | $0.3484 | 6.12M |
| Oct 29, 2026 | $0.3815 | $0.42 | $0.3785 | $0.38 | 6.6M |
| Oct 28, 2026 | $0.36 | $0.3944 | $0.36 | $0.3774 | 6.5M |
| Oct 27, 2026 | $0.36 | $0.3918 | $0.3597 | $0.3632 | 9.68M |
| Oct 26, 2026 | $0.40 | $0.4061 | $0.3626 | $0.3657 | 11.13M |
| Oct 23, 2026 | $0.42 | $0.4324 | $0.4016 | $0.4045 | 13.33M |
| Oct 22, 2026 | $0.43 | $0.4388 | $0.42 | $0.4281 | 12.5M |
| Oct 21, 2026 | $0.415 | $0.4382 | $0.386 | $0.43 | 31.69M |
| Oct 20, 2026 | $0.421 | $0.4751 | $0.405 | $0.4052 | 51.03M |
| Oct 19, 2026 | $0.5502 | $0.60 | $0.4025 | $0.44 | 184.37M |
| Oct 16, 2026 | $3.14 | $3.15 | $2.9512 | $2.99 | 2.76M |
| Oct 15, 2026 | $3.02 | $3.175 | $3.009 | $3.14 | 2.84M |
| Oct 14, 2026 | $3.04 | $3.055 | $2.93 | $3.01 | 3.16M |
| Oct 13, 2026 | $3.30 | $3.315 | $3.06 | $3.07 | 2.52M |
| Oct 12, 2026 | $3.42 | $3.4299 | $3.285 | $3.32 | 1.9M |
Latest EYPT news
The latest Smart Investors Daily articles mentioning EYPT.
Stock researchResearch & News · News
Company
Market Activity
Research & News

